A groundbreaking study reveals that a stress cardiac MRI can accurately diagnose microvascular angina in patients with chest ...

Chronic kidney disease or CKD, is a condition that builds over time, as a result of inappropriate kidney function. The ...

To address knowledge gaps, investigators conducted a meta-analysis of more than 70,000 patients in 10 trials of SGLT2 inhibitors vs placebo to determine the relative risks of CKD progression across ...

For patients with primary glomerular diseases, young patients face similar risks of kidney function decline as older patients, according to a study presented at Kidney Week, the annual meeting of the ...

A new testing protocol identifies patients whose chest pain is heart-related even though their main heart arteries look ...

Nearly all adults with chronic kidney disease (CKD) would benefit from a systolic blood pressure (BP) target <120 versus <140 ...

The phase 2 EXPLORE-CKD trial is examining the efficacy and safety of lorundrostat in addition to SGLT2 inhibitors in patients with hypertension and CKD with albuminuria.

These findings underscore the limitations of relying on proteinuria alone to assess LN treatment success and demonstrate the clinical utility of biomarker-guided risk stratification.

BRANFORD, Conn., Nov. 12, 2025 /PRNewswire/ — Azitra, Inc. (“Azitra”) (NYSE American: AZTR), a clinical stage ...

Presented robust CRB-701 clinical data at ESMO 2025 - 3.6 mg/kg dose generated ORR of 47.6% in HNSCC, 37.5% in cervical cancer and 55.6% in ...

DBM Global delivers robust revenue growth, reinforcing market leadership -- Life Sciences: MediBeacon received regulatory ...